郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.

期刊：Journal of medicinal chemistry发表年份：2006作者：Xuemei Peng; Brian I Knapp; Jean M Bidlack; John L Neumeyer
阅读更多 →

药效评价Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers.

期刊：Molecular pharmacology发表年份：2006作者：Jean-Yves Springael; Phu Nguyen Le Minh; Eneko Urizar; Sabine Costagliola; Gilbert Vassart; Marc Parmentier
阅读更多 →

药效评价Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat.

期刊：FEBS letters发表年份：2006作者：Caroline Norez; Sabrina Noel; Martina Wilke; Marcel Bijvelds; Huub Jorna; Patricia Melin; Hugo DeJonge; Frederic Becq
阅读更多 →

药效评价shRNA transcribed by RNA Pol II promoter induce RNA interference in mammalian cell.

期刊：Molecular biology reports发表年份：2006作者：Jing Yuan; Xiaobo Wang; Ying Zhang; Xiaoxiang Hu; Xuemei Deng; Jing Fei; Ning Li
阅读更多 →